Hepatitis A outbreak among MSM in Berlin due to low vaccination coverage: Epidemiology, management, and successful interventions.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 11 09 2020
revised: 04 11 2020
accepted: 06 11 2020
pubmed: 19 11 2020
medline: 26 3 2021
entrez: 18 11 2020
Statut: ppublish

Résumé

To describe the characteristics of a large hepatitis A virus (HAV) outbreak among men who have sex with men (MSM) in Berlin and to assess the impact of measures implemented. Cases of laboratory-confirmed, symptomatic HAV infection notified in Berlin, Germany between August 2016 and February 2018 were analysed using routine and enhanced surveillance data including genotyping results. Several studies involving different groups of participants were conducted to further investigate the outbreak, including surveys on knowledge and practices of HAV vaccination among physicians and vaccination coverage and determinants of vaccination status among MSM. The measures implemented were categorized by target group in a Gantt chart. To assess their impact, health insurance data on HAV vaccination uptake were analysed, comparing Berlin and other federal states. During the outbreak period, a total of 222 cases were reported (of which 91 were sequence-confirmed), with a peak in case numbers in January 2017. Physicians were aware of the existing vaccination recommendations, but vaccination coverage among 756 MSM was low, with 32.7% being completely vaccinated and 17.3% being incompletely vaccinated before 2017. HAV vaccination before 2017 was associated with being born in Germany (odds ratio 2.36) and HIV-positive (odds ratio 1.80). HAV monovalent vaccination uptake increased by 164% from 2016 to 2017 among males in Berlin, compared to 7% in other federal states. Multiple measures targeting the MSM community, physicians, and public health to increase HAV vaccination uptake were successfully implemented. To prevent future HAV outbreaks, we recommend monitoring vaccination coverage among MSM, promoting awareness of existing recommendations among physicians, and ensuring access for foreign-born and young MSM.

Identifiants

pubmed: 33207272
pii: S1201-9712(20)32327-4
doi: 10.1016/j.ijid.2020.11.133
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-153

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Ruth Zimmermann (R)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany.

Mirko Faber (M)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany. Electronic address: FaberM@rki.de.

Sandra Dudareva (S)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany.

Patrick Ingiliz (P)

Zentrum für Infektiologie, Berlin, Germany.

Heiko Jessen (H)

Praxis Jessen2 und Kollegen, Berlin, Germany.

Judith Koch (J)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany.

Ulrich Marcus (U)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany.

Kai Michaelis (K)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany.

Thorsten Rieck (T)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany.

Claudia Ruscher (C)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany; Postgraduate Training in Applied Epidemiology (PAE), Affiliated with the European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; State Office for Health and Social Affairs (LaGeSo), Berlin, Germany.

Birte Schilling (B)

Local Public Health Authority, Berlin Tempelhof-Schöneberg, Germany.

Jakob Schumacher (J)

Local Public Health Authority, Berlin Reinickendorf, Germany.

Dagmar Sissolak (D)

Local Public Health Authority, Berlin Mitte, Germany.

Janine Thoulass (J)

Department for Infectious Disease Epidemiology, Robert Koch Institute (RKI), Berlin, Germany; Postgraduate Training in Applied Epidemiology (PAE), Affiliated with the European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.

Jürgen J Wenzel (JJ)

National Consultant Laboratory for Hepatitis A and Hepatitis E, Institute of Clinical Microbiology and Hygiene, University Medical Centre Regensburg, Regensburg, Germany.

Dirk Werber (D)

State Office for Health and Social Affairs (LaGeSo), Berlin, Germany.

Daniel Sagebiel (D)

State Office for Health and Social Affairs (LaGeSo), Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH